doi: 10.1111/j.1365-2265.2004.02085.x 54 SantaguidaMGNardoSDel DucaSCLococoEViriliCGarganoLet al
The FDA endorsed several alternative GLP-1 receptor agonists to manage obesity and type 2 diabetes
Cases exposed to these two GLP-1RAs associated with GADRs were reported primarily by non-healthcare professionals (57.79% vs 67.43%), and the vast majority were from the USA (89.55% vs 89.92%)
Between his glowing eyes, ghostly giggle, and oddly aggressive balloon dog, he's guaranteed to turn casual visitors into full-on sprinters
Women using oral contraceptives should discuss additional contraceptive methods with their GP, as Mounjaro may reduce the effectiveness of these medications
Studies show: 14.9% mean weight loss vs 2.4% (~6 lb) weight loss with placebo at 68 weeks with Semaglutide 25% mean weight loss with Tirzepatide If you have diabetes, please get this medication through your primary care providers